封面
市場調查報告書
商品編碼
1314540

移植診斷市場:按產品、技術、移植、用途和最終用戶分類 - 全球預測 2023-2030 年

Transplant Diagnostics Market by Offering, Technology, Transplant, Application, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球移植診斷市場預計將以 7.42% 的複合年成長率大幅成長,到 2023 年達到 45.9778 億美元,到 2030 年將達到驚人的 76.53 億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球移植診斷市場至關重要。透過檢驗業務策略和產品滿意度的關鍵指標,我們對供應商進行全面評估,使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限,並取得了不同程度的成功:前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻,可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解:

1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。

2. 市場開發:提供有關利潤豐厚的新興市場的詳細資訊,並分析其在成熟市場的滲透率。

3. 市場多元化:提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢:全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊:對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題:

1.全球移植診斷市場規模及預測為何?

2.在預測期內,COVID-19 對全球移植診斷市場的阻礙因素與影響有哪些?

3. 在預測期內,全球移植診斷市場需要投資哪些產品/細分市場/應用/領域?

4.你們在全球移植診斷市場的競爭策略是什麼?

5.全球移植診斷市場的技術趨勢和法律規範是什麼?

6.全球移植診斷市場主要廠商的市佔率為何?

7. 哪些型態和策略措施被認為適合進入全球移植診斷市場?

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 器官捐贈意識增強,器官移植數量增加
      • 更重視移植診斷的研發
      • 新興國家醫療旅遊的成長
    • 抑制因素
      • 器官移植手術的高昂費用
    • 機會
      • 移植診斷技術不斷進步
      • 擴大器官移植的法規指南
    • 任務
      • 缺乏保險和報銷制度以及器官移植的併發症
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 移植診斷市場:透過提供

  • 樂器
  • 試劑及消耗品
  • 軟體和服務

第7章 移植診斷市場:依技術分類

  • 分子測定
  • 非分子測定

第8章 移植診斷市場

  • 軟組織移植
  • 實體器官移植
  • 幹細胞移植

第9章 移植診斷市場:依用途

  • 診斷應用
  • 研究用途

第10章 移植診斷市場:依最終用戶分類

  • 醫院及移植中心
  • 獨立標準協會
  • 研究和學術機構

第11章美洲移植診斷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太移植診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲移植診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析:主要企業
  • 競爭情境分析:主要企業
    • 併購
    • 合約、合作和夥伴關係
    • 新產品發布和功能增強
    • 獎項/獎勵/擴展

第15章上市公司名單

第16章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-031685195791

The Global Transplant Diagnostics Market is forecasted to grow significantly, with a projected USD 4,597.78 million in 2023 at a CAGR of 7.42% and expected to reach a staggering USD 7,653.00 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Transplant Diagnostics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Transplant Diagnostics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Offering, market is studied across Instruments, Reagents & Consumables, and Software & Services. The Reagents & Consumables commanded largest market share of 43.67% in 2022, followed by Instruments.

Based on Technology, market is studied across Molecular Assays and Non-Molecular Assays. The Molecular Assays commanded largest market share of 53.43% in 2022, followed by Non-Molecular Assays.

Based on Transplant, market is studied across Soft Tissue Transplant, Solid Organ Transplant, and Stem Cell Transplant. The Soft Tissue Transplant commanded largest market share of 45.14% in 2022, followed by Stem Cell Transplant.

Based on Application, market is studied across Diagnostic Applications and Research Applications. The Research Applications commanded largest market share of 67.38% in 2022, followed by Diagnostic Applications.

Based on End User, market is studied across Hospitals & Transplant Centers, Independent Reference Laboratories, and Research Laboratories & Academic Institutes. The Hospitals & Transplant Centers commanded largest market share of 47.86% in 2022, followed by Research Laboratories & Academic Institutes.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 42.12% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Transplant Diagnostics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Transplant Diagnostics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Transplant Diagnostics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Transplant Diagnostics Market?

4. What is the competitive strategic window for opportunities in the Global Transplant Diagnostics Market?

5. What are the technology trends and regulatory frameworks in the Global Transplant Diagnostics Market?

6. What is the market share of the leading vendors in the Global Transplant Diagnostics Market?

7. What modes and strategic moves are considered suitable for entering the Global Transplant Diagnostics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Transplant Diagnostics Market, by Offering, 2022 vs 2030
  • 4.3. Transplant Diagnostics Market, by Technology, 2022 vs 2030
  • 4.4. Transplant Diagnostics Market, by Transplant, 2022 vs 2030
  • 4.5. Transplant Diagnostics Market, by Application, 2022 vs 2030
  • 4.6. Transplant Diagnostics Market, by End User, 2022 vs 2030
  • 4.7. Transplant Diagnostics Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing awareness for organ donation and rise in organ transplant
      • 5.1.1.2. Increased focus on research & development of transplant diagnostics
      • 5.1.1.3. Growing medical tourism in developing countries
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with organ transplant procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing technological advancements in transplant diagnostics
      • 5.1.3.2. Growing regulatory guidelines for organ transplant
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of insurance and reimbursement policies and complications of organ transplant
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Transplant Diagnostics Market, by Offering

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Consumables
  • 6.4. Software & Services

7. Transplant Diagnostics Market, by Technology

  • 7.1. Introduction
  • 7.2. Molecular Assays
  • 7.3. Non-Molecular Assays

8. Transplant Diagnostics Market, by Transplant

  • 8.1. Introduction
  • 8.2. Soft Tissue Transplant
  • 8.3. Solid Organ Transplant
  • 8.4. Stem Cell Transplant

9. Transplant Diagnostics Market, by Application

  • 9.1. Introduction
  • 9.2. Diagnostic Applications
  • 9.3. Research Applications

10. Transplant Diagnostics Market, by End User

  • 10.1. Introduction
  • 10.2. Hospitals & Transplant Centers
  • 10.3. Independent Reference Laboratories
  • 10.4. Research Laboratories & Academic Institutes

11. Americas Transplant Diagnostics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Transplant Diagnostics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Transplant Diagnostics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player
    • 14.3.1. Merger & Acquisition
      • 14.3.1.1. Werfen to acquire transfusion and transplant diagnostics innovator for around USD 2 billion
      • 14.3.1.2. Thermo Fisher will buy the binding site for $2.6B to gain specialty diagnostics portfolio
      • 14.3.1.3. GenDx to develop NGS-Turbo following agreement with Oxford Nanopore Technologies
      • 14.3.1.4. Eurobio Scientific buys Dutch transplant diagnostics firm GenDx for €135 million
    • 14.3.2. Agreement, Collaboration, & Partnership
      • 14.3.2.1. Immucor and Pirche announce multi-year partnership
    • 14.3.3. New Product Launch & Enhancement
      • 14.3.3.1. Quest Diagnostics unveils advanced transplant diagnostic services featuring anywhere-access in the United States
      • 14.3.3.2. Eurofins Scientific SE: Transplant Genomics announces the launch of Trugraf Liver, the first and only non-invasive gene expression diagnostic test to optimize immunosuppression in liver transplant recipients
      • 14.3.3.3. Immucor announces innovations in transplant diagnostics
    • 14.3.4. Award, Recognition, & Expansion
      • 14.3.4.1. Plexision launches personalized transplant diagnostic testing in India
      • 14.3.4.2. Eurofins Viracor opens expansive laboratory in Lenexa, KS
      • 14.3.4.3. Hologic announces FDA approval of Aptima CMV Quant Assay For Human Cytomegalovirus

15. List of Company Mentioned

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. TRANSPLANT DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. TRANSPLANT DIAGNOSTICS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2022 VS 2030 (%)
  • FIGURE 5. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 6. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2022 VS 2030 (%)
  • FIGURE 7. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 8. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 9. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 10. TRANSPLANT DIAGNOSTICS MARKET DYNAMICS
  • FIGURE 11. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 20. TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 21. TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. TRANSPLANT DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 5. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 9. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NON-MOLECULAR ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 12. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SOFT TISSUE TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SOLID ORGAN TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STEM CELL TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS & TRANSPLANT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INDEPENDENT REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 116. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 127. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 132. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 137. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 142. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 147. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 152. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 157. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 162. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 167. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 172. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 177. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 182. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 187. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 192. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 202. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 207. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 212. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 217. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 232. TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 233. TRANSPLANT DIAGNOSTICS MARKET LICENSE & PRICING